1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Insomnia Treatment Drugs Market
2.3. Global Insomnia Treatment Drugs Market, By Treatment, 2025 (US$ Million)
2.4. Global Insomnia Treatment Drugs Market, By Geography, 2025 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2025
3. Insomnia Treatment Drugs Market: Competitive Analysis
3.1. Market Positioning of Key Insomnia Treatment Drugs Market Vendors
3.2. Strategies Adopted by Insomnia Treatment Drugs Market Vendors
4. Insomnia Treatment Drugs Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Insomnia Treatment Drugs Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Prescription Sleep Aids
5.3.1.1. Benzodiazepine
5.3.1.2. Antidepressant
5.3.1.3. Orexin Antagonist
5.3.2. Over the Counter (OTC) Sleep Aids
5.3.2.1. Antihistamines
5.3.2.2. Melatonin
5.3.2.3. Dietary Supplement
6. North America Insomnia Treatment Drugs Market, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
6.3. Insomnia Treatment Drugs Market: By Region, 2024-2034, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
7. UK and European Union Insomnia Treatment Drugs Market, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
7.3. Insomnia Treatment Drugs Market: By Region, 2024-2034, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
7.3.1.5. France
7.3.1.5.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
8. Asia Pacific Insomnia Treatment Drugs Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
8.3. Insomnia Treatment Drugs Market: By Region, 2024-2034, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
8.3.1.3. India
8.3.1.3.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
9. Latin America Insomnia Treatment Drugs Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
9.3. Insomnia Treatment Drugs Market: By Region, 2024-2034, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
10. Middle East and Africa Insomnia Treatment Drugs Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
10.3. Insomnia Treatment Drugs Market: By Region, 2024-2034, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Insomnia Treatment Drugs Market: By Treatment, 2024-2034, USD (Million)
11. Company Profile
11.1. F.Hoffman La-Roche AG (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
11.2. Merck & Co. Inc.
11.3. Mylan N.V.
11.4. Pernix Therapeutics
11.5. Pfizer, Inc.
11.6. Sanofi S.A.
11.7. Sumitomo Dainippon Pharma Co., Ltd
11.8. Takeda Pharmaceutical Company Ltd.
11.9. Teva Pharmaceutical Industries Ltd.
11.10. Vanda Pharmaceuticals, Inc.
